FAQs
Fully-connected continuous manufacturing™
- EnzeneX™ utilizes a patented combination of intensified perfusion and multi-column chromatography, ensuring the highest quality, efficiency, and cost-effectiveness in manufacturing
- This innovative process enables consistent and reliable production of biopharmaceutical products
Primed for product scaling
- EnzeneX™ offers scalability options, allowing you to transition from small-scale production to commercial manufacturing
- Two scaling options are available:
- Scale-on: Uses the same-size bioreactors with a higher process duration
- Scale-out: Involves multiple same-size suites, providing increased capacity
Designed with flexibility in mind
- EnzeneX™ prioritizes flexibility, enabling you to adapt to the changing demands of your biologics products
- This offers lower costs when scaling up or down production and improved sustainability by reducing carbon emissions and facility footprints
The future begins now
Your biologic deserves the most technologically advanced manufacturing process in the industry. And you deserve a new way to think about strategic partnership. Today is just the beginning.